home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

"RNAi-2005-Boston" Meeting

 
  February 04, 2005  
     
 
GeneExpression Systems, Inc., Doubletree Guest Suites, Waltham, MA, 02451 USA
May 1-3, 2005


Key Sessions:
• The Biology and Genetics of RNAi and microRNAs
• Chemical Biology and Biochemistry of RNAi
• New vectors for RNAi delivery in vivo, in vitro and in ovo
• Drug Target identification and Validation
• High throughput screenings in worms, fruit flies and humans
• Genome-wide microRNA profiling in human and mouse tissues
• Innovative strategies to develop anti-viral, ocular and cancer therapeutics
• Computational and Disease Biology of miRNAs

Target audience:
 Executives, Directors and Scientists of R&D from biotech and pharmaceuticals.
 Graduate students, Post-docs, and Professors from Academia.
 Investors, Thought leaders and Business Development people in life sciences who need to know
the emerging technologies.

 
 
Organized by: GeneExpression Systems, Inc.
Invited Speakers: “A Unique Meeting Completely Dedicated to RNAi and its Applications”

1989 Nobel Laureate Prof. Sidney Altman (Yale),
1968 Nobel Laureate Dr. Marshall Nirenberg (NIH).
Innovators Roland Plasterk (Netherlands), David Bartel (MIT), and authorities in the RNAi field including: Nassim Usman (Sirna Therapeutics), John Maraganore (Alnylam), Roberto Weinmann (Bristol Myers Squibb), Inder Verma (Salk Inst), Kerry Lowrie (Invitrogen), Connie Cepko (Harvard), Kazunari Taira UTokyo, Japan), K. Latham (Ambion), Eric Lader (Qiagen), Joerg Rippman (Boehringer-Ingelheim, Germany), Carl Novina (Dana-Farber Cancer Inst), William Marshall (Dharmacon), Esther Stoekli (Zurich, Switzerland), Carlo Croce (OSU), M. Abdelrahim (Texas A&M), Mark Behlke (IDT), Pal Straem (Interagon, Norway), Tarif Awad (Affymetrix), Ron Herzig (Upstate/Chemicon), Sakari Kauppinen (exiqon, Denmark), Stefen Panzner (Novosom, Germany), T. Mizutani (B-Bridge), Zvi Bentwich (Rosetta Genomics, Israel), Michelle Lyles (Genospectra), Kader Thiam (genOway, France), Anna Krichevsky (Harvard) and several other academic, biotech and pharmaceutical Communities will be speaking on the biology of RNAi and their utilizations in Target validation, drug and therapeutic development.

 
Deadline for Abstracts: March 20, 2005
 
Registration: From $699
E-mail: Genexpsys@expressgenes.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.